BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Atorvastatin acetonide methyl ester | Atorvastatin acetonide methyl ester is the impuritiy of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Synonyms: Methyl [(4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate; methyl 2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate. CAS No. 1353049-81-6. Molecular formula: C37H41FN2O5. Mole weight: 612.73. |  |
| Atorvastatin Acetonide t-Butyl Ester Side Chain (4R,6S)-Isomer | Atorvastatin Acetonide t-Butyl Ester Side Chain (4R,6S)-Isomer is the impuritiy of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Synonyms: tert-butyl 2-((4R,6S)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate; (4R,6S)-6-(Cyanomethyl)-2,2-dimethyl--1,3-dioxane-4-acetic Acid tert-Butyl Ester; (4R-trans)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester. CAS No. 196085-84-4. Molecular formula: C14H23NO4. Mole weight: 269.34. | |
| Atorvastatin acyl-b-D-glucuronide | Atorvastatin acyl-b-D-glucuronide is a compound used in biomedicine to study the metabolism of Atorvastatin, a cholesterol-lowering drug. It is an intermediate formed during the elimination of Atorvastatin from the body. Synonyms: Atorvastatin Acyl-beta-D-glucuronide. CAS No. 463962-58-5. Molecular formula: C39H45FN2O11. Mole weight: 736.80. | |
| Atorvastatin-Amlodipine Adduct | Atorvastatin-Amlodipine Adduct is an impurity of Amlodipine. Amlodipine is a long-acting dihydropyridine L-type calcium channel blocker. Amlodipine is used to lower blood pressure and prevent chest pain. Synonyms: 3-Ethyl 5-Methyl 4-(2-Chlorophenyl)-2-[[2-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]ethoxy]methyl]-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate. CAS No. 425408-16-8. Molecular formula: C53H58ClFN4O9. Mole weight: 949.5. | |
| Atorvastatin calcium trihydrate | Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol. Uses: An inhibitor of hmg-coa reductase used as a cholesterol-lowering medication that blocks the production of cholesterol. Synonyms: CI-981; CI 981; CI981; calcium bis{(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate} trihydrate. Grade: ≥98%. CAS No. 344423-98-9. Molecular formula: C66H74CaF2N4O13. Mole weight: 1209.40. | |
| Atorvastatin Cyclic (Fluorophenyl) Sodium Salt Impurity | An impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Synonyms: ATV-FX1 sodium salt. CAS No. 1315629-79-8. Molecular formula: C33H34FN2NaO7. Mole weight: 612.62. | |
| Atorvastatin Cyclic Isopropyl Impurity | Atorvastatin Cyclic Isopropyl Impurity is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: 4-{6-(4-Fluorophenyl)-7,8-epoxy-6-hydroxy-8a-isopropyl-7-phenyl-8-(phenylcarbamoyl)hexahydro-2H-pyrrolo[2,1-b][1,3]oxazin-2-yl}-3-. hydroxybutanoic acid; Atorvastatin epoxy pyrrolooxazin 6-hydroxy analog; Atorvastatin FXA Impurity; 3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 7-(4-fluorophenyl)hexahydro-β,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-; 7-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid. Grade: 90%. CAS No. 873950-17-5. Molecular formula: C33H35FN2O7. Mole weight: 590.65. | |
| Atorvastatin Cyclic Sodium Salt (Fluorophenyl) Impurity | Atorvastatin Cyclic Sodium Salt (Fluorophenyl) Impurity is a photodegadation product of Atorvastatin. It is a cyclic impurity of Atorvastatin. Synonyms: 1b-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic Acid Sodium; ATV-cycloFP Sodium; ATV-FX1 sodium salt. Grade: > 95%. CAS No. 873950-18-6. Molecular formula: C33H34FN2O7Na. Mole weight: 612.62. | |
| Atorvastatin Cyclic Sodium Salt (Isopropyl) Impurity | An impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Synonyms: 4-{6-(4-Fluorophenyl)-7,8-epoxy-6-hydroxy-8a-isopropyl-7-phenyl-8-(phenylcarbamoyl)hexahydro-2H -pyrrolo[2,1-b][1,3]oxazin-2-yl}-3-hydroxybutanoic acid sodium salt; Atorvastatin Cyclic Isopropyl Impurity; Atorvastatin Epoxy Pyrrolooxazin 6-Hydroxy Analog (USP); Atorvastatin Cyclic 6-Hydroxy Impurity. Grade: 90%. CAS No. 1316291-19-6. Molecular formula: C33H34FN2NaO7. Mole weight: 612.62. | |
| Atorvastatin Dehydro Lactone | Atorvastatin Dehydro Lactone is an intermediate in the preparation of Atorvastatin and its derivatives. Synonyms: 3-Dehydroxy 2,3-Dehydro Atorvastatin Lactone; 1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide. Grade: > 95%. CAS No. 442851-50-5. Molecular formula: C33H31FN2O3. Mole weight: 522.63. | |
| Atorvastatin Di-acetonide tert-Butyl Ester | Atorvastatin Di-acetonide tert-Butyl Ester is the impurity of Atorvastatin, which is a selective, competitive HMG-CoA reductase inhibitor. Synonyms: 2-Methyl-2-propanyl {(4R,6R)-6-[2-({[(4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetyl}amino)ethyl]-2,2-dimethyl-1,3-d ioxan-4-yl}acetate; 1,1-Dimethylethyl (4R,6R)-6-[2-[[2-[(4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetyl]amino]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate. CAS No. 1116118-82-1. Molecular formula: C50H64FN3O8. Mole weight: 854.06. | |
| Atorvastatin Diketo Amide 2 | Atorvastatin Diketo Amide 2 is the impuritiy of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Synonyms: 2-(2-(2-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenylpentanamide. CAS No. 1797905-42-0. Molecular formula: C26H24FNO3. Mole weight: 417.47. | |
| Atorvastatin EP Impurity A | Atorvastatin EP Impurity A is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3R,5R)-3,5-Dihydroxy-7-[5-(1-methylethyl)-2,3-diphenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]heptanoic acid; Desfluoroatorvastatin; Defluoro Atorvastatin; 1H-Pyrrole-1-heptanoic acid, β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-, (βR,δR)-; (βR,δR)-β,δ-Dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; Atorvastatin impurity A; Atorvastatin calcium trihydrate impurity A [EP]. Grade: ≥95%. CAS No. 433289-84-0. Molecular formula: C33H36N2O5. Mole weight: 540.65. | |
| Atorvastatin EP Impurity A sodium salt | An impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Synonyms: Atorvastatin Impurity A sodium salt; 1H-Pyrrole-1-heptanoic acid, β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-, sodium salt (1:1), (βR,δR)-; (3R,5R)-3,5-Dihydroxy-7-[5-(1-methylethyl)-2,3-diphenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]heptanoic acid sodium salt; Desfluoroatorvastatin sodium salt; Defluoro Atorvastatin sodium salt; (βR,δR)-β,δ-Dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid sodium salt; Atorvastatin calcium trihydrate impurity A [EP] sodium salt. Grade: ≥95%. CAS No. 1516864-05-3. Molecular formula: C33H35N2NaO5. Mole weight: 562.64. | |
| Atorvastatin EP Impurity B | Atorvastatin EP Impurity B is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3RS,5SR)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic Acid; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-; 2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; Atorvastatin Calcium Impurity B; Atorvastatin calcium trihydrate impurity B [EP]. Grade: ≥95%. CAS No. 842103-12-2. Molecular formula: C33H35FN2O5. Mole weight: 558.65. | |
| Atorvastatin EP Impurity C | Atorvastatin EP Impurity C is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3R,5R)-7-[2,3-bis(4-fluorophenyl)-5-(1-methylethyl)-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; Fluoroatorvastatin; (3R,5R)-7-(2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid; Difluoro Atorvastatin; Atorvastatin Impurity C; Atorvastatin calcium trihydrate impurity C [EP]; 1H-Pyrrole-1-heptanoic acid, 2,3-bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-, (βR,δR)-; (βR,δR)-2,3-Bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid. Grade: ≥95%. CAS No. 693794-20-6. Molecular formula: C33H34F2N2O5. Mole weight: 576.63. | |
| Atorvastatin EP Impurity D | Atorvastatin EP Impurity D is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: 3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide; 3-(4-fluorobenzoyl)-2-isobutyryl-N,3-diphenyloxirane-2-carboxamide; Atorvastatin Epoxydione Impurity; 2-Oxiranecarboxamide, 3-(4-fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyl-; 3-(4-Fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyl-2-oxiranecarboxamide; USP Atorvastatin Related Impurity D; Atorvastatin EP Impurity D; Atorvastatin USP Related Compound D; Atorvastatin calcium trihydrate impurity D [EP]. Grade: ≥95%. CAS No. 148146-51-4. Molecular formula: C26H22FNO4. Mole weight: 431.47. | |
| Atorvastatin EP Impurity E | Atorvastatin EP Impurity E is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3S,5S)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; ent-Atorvastatin; S,S-Atorvastatin; (βS,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid; 3S,5S-Atorvastatin; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βS,δS)-; (3S,5S)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic Acid; Atorvastatin calcium trihydrate impurity E [EP]. Grade: ≥95%. CAS No. 501121-34-2. Molecular formula: C33H35FN2O5. Mole weight: 558.64. | |
| Atorvastatin EP Impurity F | Atorvastatin EP Impurity F is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoic acid; Atorvastatin EP Impurity F; Atorvastatin calcium trihydrate impurity F [EP]; Heptanoic acid, 7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-, (3R,5R)-; (3R,5R)-7-((3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanamido)-3,5-dihydroxyheptanoic acid; Atorvastatin diamino [USP impurity]; Atorvastatin amide. Grade: ≥95%. CAS No. 887196-24-9. Molecular formula: C40H48FN3O8. Mole weight: 717.82. | |
| Atorvastatin EP Impurity G | Atorvastatin EP Impurity H is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-5-hydroxy-3-methoxyheptanoic acid; 3-O-Methylatorvastatin; Atorvastatin Impurity G; Atorvastatin calcium trihydrate impurity G [EP]; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-δ-hydroxy-β-methoxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δR)-; (βR,δR)-2-(4-Fluorophenyl)-δ-hydroxy-β-methoxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxy-3-methoxyheptanoic acid. Grade: ≥95%. CAS No. 887324-53-0. Molecular formula: C34H37FN2O5. Mole weight: 572.67. | |
| Atorvastatin EP Impurity H | Atorvastatin EP Impurity G is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (4R,6R)-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2H-pyran-2-one; Atorvastatin Lactone; 5-(4-fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide; 5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide; Atorvastatin δ-Lactone; 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-; 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-, (2R-trans)-; 5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide; Atorvastatin USP Related Compound H; USP Atorvastatin Related Compound H; Atorvastatin Lactone Impurity; Atorvastatin calcium trihydrate impurity H [EP]. Grade: ≥95%. CAS No. 125995-03-1. Molecular formula: C33H33FN2O4. Mole weight: 540.64. | |
| Atorvastatin epoxy pyrrolooxazin 7-hydroxy analog | Atorvastatin epoxy pyrrolooxazin 7-hydroxy analog is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3R)-4-(1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2',3':3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoic acid; (3R)-4-[1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl]-3-hydroxybutanoic acid; 3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR)-. Grade: ≥95%. Molecular formula: C33H35FN2O7. Mole weight: 590.64. | |
| Atorvastatin epoxy pyrrolooxazin 7-hydroxy analog ((3R)-isomer) | Atorvastatin epoxy pyrrolooxazin 7-hydroxy analog ((3R)-isomer) is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: 3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)-; (βR,3R)-1b-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid. Grade: ≥95%. CAS No. 1193817-52-5. Molecular formula: C33H35FN2O7. Mole weight: 590.65. | |
| Atorvastatin Epoxy Tetrahydrofuran Impurity | Atorvastatin Epoxy Tetrahydrofuran Impurity is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: 4-(4-Fluorophenyl)-2,4-dihydroxy-2-isopropyl-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide; Atorvastatin epoxy tetrahydrofuran analog; 4-(4-Fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide; Atorvastatin Photo Degradation Product; 3,6-Dioxabicyclo[3.1.0]hexane-1-carboxamide, 4-(4-fluorophenyl)-2,4-dihydroxy-2-(1-methylethyl)-N,5-diphenyl-; Atorvastatin epoxy THF analog. Grade: ≥95%. CAS No. 873950-19-7. Molecular formula: C26H24FNO5. Mole weight: 449.48. | |
| Atorvastatin Ethyl Ester | Atorvastatin Ethyl Ester is the impurity of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Synonyms: (3R,5R)-Ethyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, ethyl ester, (βR,δR)-; Ethyl (βR,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate; Ethyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate. Grade: ≥95%. CAS No. 1146977-93-6. Molecular formula: C35H39FN2O5. Mole weight: 586.71. | |
| Atorvastatin Impurity 14 | Atorvastatin Impurity 14 is a intermediate in the preparation of Atorvastatin 10-Trans. Synonyms: (4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester; (4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester; (4S-trans)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Este. Grade: > 95%. CAS No. 186508-95-2. Molecular formula: C14H23NO4. Mole weight: 269.34. | |
| Atorvastatin Impurity 15 | Atorvastatin Impurity 15 is an impurity in Atorvastatin, a medication used to lower cholesterol levels and prevent heart-related conditions. Synonyms: 4-Fluoro Atorvastatin Calcium Salt; 693793-42-9. Grade: > 95%. CAS No. 693793-42-9. Molecular formula: C33H33F2N2O5. Mole weight: 575.64. | |
| Atorvastatin Impurity 16 | Atorvastatin Impurity 16 is an impurity of atorvastatin. Atorvastatin contributes to the proficient treatment of conditions pervading elevated cholesterol levels and atherosclerosis. Synonyms: Atorvastatin Impurity 16; 1450739-65-7. Grade: > 95%. CAS No. 1450739-65-7. Molecular formula: C40H47FN2O8. Mole weight: 702.83. | |
| Atorvastatin Impurity 17 | Atorvastatin Impurity 17 is an impurity of Atorvastatin. Synonyms: 2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethylidene]-4-methyl-3-oxo-N-phenylpentanamide; ATS Diketoene. Grade: > 95%. CAS No. 1331869-19-2. Molecular formula: C26H22FNO3. Mole weight: 415.47. | |
| Atorvastatin Impurity F | Atorvastatin Impurity F is an impurity of Atorvastatin, a medication commonly prescribed to lower cholesterol and reduce the risk of heart attacks or strokes. Synonyms: (Amide Impurity) Sodium Salt. Grade: > 95%. CAS No. 1371615-56-3. Molecular formula: C40H47FN3O8Na. Mole weight: 739.82. | |
| Atorvastatin Lactam Impurity | Atorvastatin Lactam Impurity is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3R,5R)-7-[5-(4-Fluorophenyl)-3-isopropyl-2-oxo-4-phenyl-3-(phenylcarbamoyl)-2,3-dihydro-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; Atorvastatin Pyrrolidone Analog (USP); 1H-Pyrrole-1-heptanoic acid, 5-(4-fluorophenyl)-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-4-phenyl-3-[(phenylamino)carbonyl]-, (βR,δR)-; (βR,δR)-5-(4-Fluorophenyl)-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-4-phenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; (3R,5R)-3,5-Dihydroxy-7-[2-oxo-3-isopropyl-3-(phenylcarbamoyl)-4-phenyl-5-(4-fluorophenyl)-2,3-dihydro-1H-pyrrole-1-yl]heptanoic acid; Atorvastatin EP Impurity Q. Grade: ≥95%. CAS No. 906552-18-9. Molecular formula: C33H35FN2O6. Mole weight: 574.65. | |
| Atorvastatin Lactam Phenanthrene Calcium Salt | Atorvastatin Lactam Phenanthrene Calcium Salt is Atorvastatin impurity and a stable Atorvastatin formulation. Synonyms: Atorvastatin Lactam Phenanthrene Calcium Salt Impurity (mixture of diastereomers); [3R-[1(βR*,δR*),3R*]]-9-Fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)- 2-oxo-3-[(phenylamino)carbonyl]-1H-dibenz[e,g]indole-1-heptanoic Acid Calcium Salt. Grade: > 95%. CAS No. 148127-12-2. Molecular formula: C33H32FN2O6Ca1/2. Mole weight: 591.67. | |
| Atorvastatin Lactam Sodium Salt Impurity | Atorvastatin Lactam Sodium Salt Impurity is a photodegradation product of Atorvastatin. It is a cyclic impurity of Atorvastatin. Synonyms: 1H-Pyrrole-1-heptanoic acid, 5-(4-fluorophenyl)-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-4-phenyl-3-[(phenylamino)carbonyl]-, sodium salt (1:1), (βR,δR,3R)-; 1H-Pyrrole-1-heptanoic acid, 5-(4-fluorophenyl)-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-4-phenyl-3-[(phenylamino)carbonyl]-, monosodium salt, [3R-[1(βR*,δR*),3R*]]-; Atorvastatin Lactam Sodium Salt Impurity (3R-isomer); sodium (3R,5R)-7-((R)-5-(4-fluorophenyl)-3-isopropyl-2-oxo-4-phenyl-3-(phenylcarbamoyl)-2,3-dihydro-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate. Grade: ≥95%. CAS No. 148217-40-7. Molecular formula: C33H34FN2O6Na. Mole weight: 596.62. | |
| Atorvastatin lactone diepoxide | A derivative of Atorvastatin, a statin medication used to treat cardiovascular disease. Synonyms: Atorvastatin diepoxide (Lactone ring); 4-(4-Fluorophenyl)-6-(1-methylethyl)-N,2-diphenyl-5-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-3,7-dioxa-5-azatricyclo[4.1.0.02,4]heptane-1-carboxamide; 4-(4-Fluorophenyl)-5-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-6-isopropyl-N,2-diphenyl-3,7-dioxa-5-azatricyclo[4.1.0.02,4]heptane-1-carboxamide. Grade: ≥95%. CAS No. 2591410-14-7. Molecular formula: C33H33FN2O6. Mole weight: 572.62. | |
| Atorvastatin Lactone Diepoxide (Mixture of diastereomers) | A derivative of Atorvastatin, a statin medication used to treat cardiovascular disease. Synonyms: 4-(4-Fluorophenyl)-6-(1-methylethyl)-N,2-diphenyl-5-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-3,7-dioxa-5-azatricyclo[4.1.0.02,4]heptane-1-carboxamide; 4-(4-Fluorophenyl)-5-(2-(4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-6-isopropyl-N,2-diphenyl-3,7-dioxa-5-azatricyclo[4.1.0.02,4]heptane-1-carboxamide. Grade: ≥95%. CAS No. 1046118-40-4. Molecular formula: C33H33FN2O6. Mole weight: 572.64. | |
| Atorvastatin Methyl Ester | Atorvastatin Methyl Ester is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Methyl Ester; (3R,5R)-Methyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbaMoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, methyl ester, (βR,δR)-; Methyl (βR,δR)-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate. Grade: ≥95%. CAS No. 345891-62-5. Molecular formula: C34H37FN2O5. Mole weight: 572.68. | |
| Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide | Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide is a prominent compound in the research of dyslipidemia and associated cardiovascular disorders. Its efficacious mechanism of action lies in its tremendous capacity to inhibit HMG-CoA reductase, a pivotal enzyme profoundly engaged in the intricate process of cholesterol biosynthesis. Uses: Atorvastatin (a791750) impurity. Synonyms: (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-heptanoic Acid Calcium Salt. Grade: 95%. CAS No. 1105067-87-5. Molecular formula: C40H48FN3O8?0.5Ca. Mole weight: 736.86. | |
| Atorvastatin pyrrolidone lactone | Atorvastatin pyrrolidone lactone is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: 5-(4-Fluorophenyl)-1-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3-isopropyl-2-oxo-N,4-diphenyl-2,3-dihydro-1H-pyrrole-3-carboxamide; (3R,5R)-3,5-Dihydroxy-7-[2-oxo-3-isopropyl-3-(phenylcarbamoyl)-4-phenyl-5-(4-fluorophenyl)-2,3-dihydro-1H-pyrrole-1-yl]heptanoic acid 1,5-lactone; 1H-Pyrrole-3-carboxamide, 5-(4-fluorophenyl)-2,3-dihydro-3-(1-methylethyl)-2-oxo-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-; 5-(4-Fluorophenyl)-2,3-dihydro-3-(1-methylethyl)-2-oxo-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide. Grade: ≥95%. CAS No. 906552-19-0. Molecular formula: C33H33FN2O5. Mole weight: 556.62. | |
| Atorvastatin Sodium | Atorvastatin, a HMG-CoA reductase inhibitor, could be used to reduce cholesterol and prevent cardiovascular related disease. Synonyms: [R-(R',R')]-2-(4-Fluorophenyl)-3-phenyl-4-[(phenylamino)carbonyl]-5-(1-methylethyl)-1-H-pyrrol-1-(-dihydrogen)heptanoic acid sodium. Grade: 95%. CAS No. 134523-01-6. Molecular formula: C33H34FN2NaO5. Mole weight: 580.62. | |
| Atorvastatin tert-Butyl Ester | Atorvastatin tert-Butyl Ester is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3R,5R)-tert-Butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βR,δR)-; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, [R-(R*,R*)]-; (3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid tert-butyl ester. Grade: ≥95%. CAS No. 134395-00-9. Molecular formula: C37H43FN2O5. Mole weight: 614.76. | |
| Atorvastatin USP Related Compound A | Atorvastatin USP Related Compound A is an impurity in the synthesis of Atorvastatin, which is a competitive HMG-CoA reductase inhibitor. Atorvastatin is a lipid-lowering medication of the statin class. Atorvastatin suppresses the production of cholesterol and prevents some cardiovascular diseases. Synonyms: Calcium (3R,5R)-7-[2-isopropyl-4,5-diphenyl-3-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin Desfluoro impurity; (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoicacid, calcium salt; USP Atorvastatin Related Compound A; Defluoro Atorvastatin Calcium Salt; Atorvastatin Related Compound A; Calcium (3R,5R)-3,5-dihydroxy-7-(2-isopropyl-4,5-diphenyl-3-(phenylcarbamoyl)-1H-pyrrol-1-yl)heptanoate; 1H-Pyrrole-1-heptanoic acid, β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-; Calcium (βR,δR)-β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2). Grade: ≥95%. CAS No. 433289-83-9. Molecular formula: C66H70CaN4O10. Mole weight: 1119.38. | |
| Atorvastatin USP Related Compound B | Atorvastatin USP Related Compound B is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: (3S,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (3S,5R)-Atorvastatin; Atorvastatin 3S,5R Isomer; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βS,δR)-; (βS,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid. Grade: ≥95%. CAS No. 887324-52-9. Molecular formula: C33H35FN2O5. Mole weight: 558.64. | |
| Atorvastatin USP Related Compound B calcium salt | Atorvastatin USP Related Compound B is an impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Synonyms: USP Atorvastatin Related Compound B; Calcium (3S,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin 3S,5R Isomer; (3S,5R)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt; (βS,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βS,δR)-; Atorvastatin Related Compound B; (3S,5R)-Atorvastatin Calcium Salt. Grade: ≥95%. CAS No. 887196-25-0. Molecular formula: C66H68CaF2N4O10. Mole weight: 1155.34. | |
| Atorvastatin USP Related Compound C | Atorvastatin USP Related Compound C is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: USP Atorvastatin Related Compound C; Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin Difluoro impurity; (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt; (βR,δR)-2,3-Bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt; 1H-Pyrrole-1-heptanoic acid, 2,3-bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-; Atorvastatin Related Compound C; Difluoro Atorvastatin Calcium Salt. Grade: ≥95%. CAS No. 693793-53-2. Molecular formula: C66H66CaF4N4O10. Mole weight: 1191.32. | |
| Atorvastatin USP Related Compound E | Atorvastatin USP Related Compound E is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: USP Atorvastatin Related Compound E; Calcium (3S,5S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2); Atorvastatin 3S,5S Enantiomer; (3S,5S)-7-[3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, calcium salt; Atorvastatin Related Compound E; (3S,5S)-Atorvastatin Calcium Salt; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βS,δS)-. Grade: ≥95%. CAS No. 1105067-88-6. Molecular formula: C66H68CaF2N4O10. Mole weight: 1155.38. | |
| Atorvastatin USP Related Compound I | Atorvastatin USP Related Compound I is an impurity of Atorvastatin, which is an HMG-CoA reductase inhibitor used to reduce cholesterol and prevent cardiovascular-related disease. Synonyms: USP Atorvastatin Related Compound I; Atorvastatin acetonide impurity; tert-Butyl 2-((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl)acetate; Atorvastatin Acetonide tert-Butyl Ester; (4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester; Atorvastatin EP Impurity I; 1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6R)-; 1,1-Dimethylethyl (4R,6R)-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate; 1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R-cis)-. Grade: ≥95%. CAS No. 125971-95-1. Molecular formula: C40H47FN2O5. Mole weight: 654.83. | |
| Atosiban Acetate | Atosiban Acetate is an oxytocin receptor blocking agent in the treatment of experimental endometriosis and is shown exhibit significant therapeutic efficiency. It is clinically used to decrease uterine contractility in the prevention of pre-term birth. Synonyms: Glycinamide, O-ethyl-N-(3-mercapto-1-oxopropyl)-D-tyrosyl-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-ornithyl-, cyclic (1→5)-disulfide, acetate (1:1); Cyclic (1→5)-disulfide O-Ethyl-N-(3-mercapto-1-oxopropyl)-D-tyrosyl-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-ornithyl-glycinamide Monoacetate; Antocile Acetate; CAP 449 Acetate; CAP 476 Acetate; CAP 581 Acetate; F 314 Acetate; ORF 22164 Aceta; Tractocil; Tractocile; Deamino-cysteinyl-O4-ethyl-D-tyrosyl-L-isoleucyl-L-threonyl-L-asparagyl-L-cysteinyl-L-prolyl-L-ornithyl-glycinamide (1->6)-disulfide acetate; deamino-Cys-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2.CH3CO2H (Disulfide bridge: Cys1-Cys6). Grade: >95%. CAS No. 914453-95-5. Molecular formula: C45H71N11O14S2. Mole weight: 1054.26. | |
| Atosiban Dimer (Antiparallel) | An impurity of Atosiban. Atosiban is a synthetic peptide that acts as a selective oxytocin receptor antagonist, primarily used to delay preterm labor in pregnant women. Synonyms: Mpr-DTyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2(Mpr1&Cys6, Cys6&Mpr1 bridge); Atosiban Dimer(antiparallel); deamino-Cys-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2.deamino-Cys-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2 (Disulfide bridge: Cys1-Cys6', Cys6-Cys1'). Grade: ≥95%. CAS No. 2408121-12-8. Molecular formula: C86H134N22O24S4. Mole weight: 1988.39. | |
| Atosiban Dimer (parallel) | An impurity of Atosiban. Atosiban is a synthetic peptide that acts as a selective oxytocin receptor antagonist, primarily used to delay preterm labor in pregnant women. Synonyms: Mpr-DTyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2(Mpr1&Mpr1, Cys6&Cys6 bridge); Atosiban Dimer(parallel); deamino-Cys-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2.deamino-Cys-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2 (Disulfide bridge: Cys1-Cys1', Cys6-Cys6'). Grade: ≥95%. CAS No. 2408121-11-7. Molecular formula: C86H134N22O24S4. Mole weight: 1988.39. | |
| Atovaquone EP Impurity B | Atovaquone EP Impurity B is the cis-isomer of Atovaquone, which is a hydroxynaphthoquinone derivative that inhibits mitochondrial electron transport. Uses: Antipneumocystic. Synonyms: cis-Atovaquone; 1,4-Naphthalenedione,2-[cis-4-(4-chlorophenyl)cyclohexyl]-3- hydroxy-; Atovaquone Related Compound A; cis-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione. Grade: > 95%. CAS No. 137732-39-9. Molecular formula: C22H19ClO3. Mole weight: 366.85. | |
| Atovaquone Impurity 1 | Atovaquone Impurity 1 is an intermediate used to prepare 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer. It is also used in the synthesis of aminothiazole derivatives as inhibitors of action of AgRP on a melanocortin receptor. Synonyms: trans-4-(4-Chlorophenyl)-1-acetylcyclohexane; Atovaquone intermediate; trans-4-(p-Chlorophenyl)-1-acetylcyclohexane. Grade: > 95%. CAS No. 91161-85-2. Molecular formula: C14H17ClO. Mole weight: 236.74. | |
| Atovaquone Impurity 2 | Atovaquone Impurity 2 is an impurity of Atovaquone, which is a medication used to treat or prevent pneumocystis pneumonia, toxoplasmosis, malaria, and babesia. Synonyms: Cyclohexanecarboxylic acid, 4-(4-chlorophenyl)-, trans-; trans-4-(4-Chlorophenyl)cyclohexanecarboxylic acid; trans-4-(p-Chlorophenyl)cyclohexanecarboxylic acid. Grade: ≥95%. CAS No. 49708-81-8. Molecular formula: C13H15ClO2. Mole weight: 238.72. | |
| Atovaquone Impurity 3 | Atovaquone Impurity 3 is an impurity of Atovaquone, the pharmaceutical targeting a myriad of illnesses, with a special emphasis on malaria. Synonyms: 1-[4-(4-Chlorophenyl)cyclohexyl]-Ethanone; 4'-Acetylcyclohexyl-4-chlorobenzene; 4'-Acetylcyclohexyl chlorobenzene. Grade: > 95%. CAS No. 95233-36-6. Molecular formula: C14H17ClO. Mole weight: 236.74. | |
| Atovaquone Related Compound 1 | Atovaquone Related Compound 1 is an impurity of Atovaquone. Synonyms: cis-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid. Grade: > 95%. CAS No. 1346600-43-8. Molecular formula: C13H15ClO2. Mole weight: 238.72. | |
| ATP, 100mM Sodium Solution | The solution form of ATP, a nucleotide and a small molecule used in cells as a coenzyme. Synonyms: Adenosine 5'-triphosphate, Sodium salt. Grade: ≥ 99% by HPLC. Molecular formula: C10H16N5O13P3 (free acid). Mole weight: 507.18 (free acid). | |
| ATPA | ATPA is a potent and selective GluR5 kainate receptor agonist with Ki value of 4.3 nM. It is weakly active at AMPA receptors (GluR1-4), GluR7 and the kainate receptors KA-2. Synonyms: 4-Isoxazolepropanoic acid, α-amino-5-(1,1-dimethylethyl)-2,3-dihydro-3-oxo-; (RS)-2-Amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid; α-Amino-5-(1,1-dimethylethyl)-2,3-dihydro-3-oxo-4-isoxazolepropanoic acid; 2-Amino-3-(5-(tert-butyl)-3-hydroxyisoxazol-4-yl)propanoic acid; 2-Amino-3-(5-tert-butyl-3-hydroxy-1,2-oxazol-4-yl)propanoic acid; 2-Amino-3-[3-hydroxy-5-tert-butylisoxazol-4-yl]propanoic acid; (R,S)-ATPA. Grade: ≥98% by HPLC. CAS No. 140158-50-5. Molecular formula: C10H16N2O4. Mole weight: 228.25. | |
| ATPαS | ATPαS is an exceptional analogue of adenosine triphosphate (ATP), finding extensive utilization in expounding ATP-regulated enzyme kinetics and underlying mechanisms. Its principal application encompasses delving into the intricacies of ATP-dependent protein kinases thereby aiding in the comprehensive comprehension of their functionality and regulation. Synonyms: Adenosine, 5'→P''-ester with thiotriphosphoric acid; Adenosine-5'-RP-alpha-thio-triphosphate; Adenosine-5'-O-(1-Thiotriphosphate); Thiotriphosphoric acid ((HO)2P(O)OP(O)(OH)OP(S)(OH)2), P''→5'-ester with adenosine; ATP-α-S; α-Thio-dATP; ATP-αS. Grade: ≥95% by HPLC. CAS No. 29220-54-0. Molecular formula: C10H16N5O12P3S. Mole weight: 523.25. | |
| ATP-γ-AmNS | ATP-γ-AmNS, the biochemical component that elevates ATP potency in the human body, presents a groundbreaking solution to energy supply deficits, manifesting in various metabolic disorders and mitochondrial malfunctions. Its exceptional efficacy in combating these ailments, by increasing energy availability and function, yields a profound impact on overall health. Thus, ATP-γ-AmNS has become an inexorable asset in biomedicine, revolutionizing the therapeutic landscape. Synonyms: Adenosine-5'-triphosphate-γ-(sulfo-1-naphthyl)amide, Triethylammonium salt. Grade: ≥ 95% by HPLC. Molecular formula: C20H23N6O15P3S (free acid). Mole weight: 712.41 (free acid). | |
| ATPγS | ATPγS is an agonist of G protein-coupled P2Y2 and P2Y11 receptors (pEC50 = 5.52 for P2Y11). It has been used to identify kinase substrates, used as a reagent in the synthesis of DNA N-acetylglucosamine analogs and a substrate for the RNA-stimulated nucleotide hydrolysis as well as RNA unwinding activities of eukaryotic initiation factor-4A. Uses: Atpγs is an agonist of g protein-coupled p2y2 and p2y11 receptors (pec50 = 5.52 for p2y11). Synonyms: Adenosine-5'-(γ-thio)-triphosphate, Tetralithium salt; Adenosine-5'-(3-thio)-triphosphate, Adenosine-5'-(3-thiotriphosphate). Grade: ≥ 90% by HPLC, contains < 10% ADP. Molecular formula: C10H16N5O12P3S (free acid). Mole weight: 523.24 (free acid). | |
| ATPγS tetralithium salt | Adenosine 5'-(γ-thio)-triphosphate lithium salt is a stable analog of ATP. It is a potent agonist of G protein-coupled P2Y2 and P2Y11 receptors. Adenosine 5'-(γ-thio)-triphosphate has also been used to identify kinase substrates and can serve as a substrate for the RNA-stimulated nucleotide hydrolysis and RNA unwinding activities of eukaryotic initiation factor-4A. Uses: Affinity labels. Synonyms: Adenosine-5'-(γ-thio)-triphosphate tetralithium salt. Grade: ≥90% by HPLC. CAS No. 93839-89-5. Molecular formula: C10H12Li4N5O12P3S. Mole weight: 546.98. | |
| ATP - lyophilized | The lyophilized form of ATP, a nucleotide and a small molecule used in cells as a coenzyme. Synonyms: Adenosine 5'-triphosphate, Disodium salt trihydrate. Grade: ≥ 98% by HPLC. Molecular formula: C10H14N5Na2O13P3* 3H2O. Mole weight: 605.18 (free acid). | |
| ATP synthase inhibitor 1 | ATP synthase inhibitor 1 is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex, inhibits mitochondrial permeability transition pore (mPTP) opening, does not affect ATP levels. Synonyms: 1,3,8-Triazaspiro[4.5]decan-4-one, 8-[(5-chloro-2-thienyl)sulfonyl]-1-phenyl-. Grade: 99%. CAS No. 1023043-30-2. Molecular formula: C17H18ClN3O3S2. Mole weight: 411.93. | |
| ATP-y-F | ATP-y-F is a synthetic derivative of adenosine triphosphate (ATP). It is commonly used in biomedical research for its ability to mimic ATP and modulate enzymatic activity. ATP-y-F plays a crucial role in studying ATP-dependent processes and understanding the mechanisms underlying compound resistance as well as exploring potential therapeutic strategies for various diseases related to ATP dysregulation. Synonyms: (ApppF); Adenosine-5'-(γ-fluoro)-triphosphate, Sodium salt; Adenosine-5'-(3-fluoro)-triphosphate, Sodium salt. Grade: ≥ 95% by HPLC. CAS No. 37515-63-2. Molecular formula: C10H15FN5O12P3 (free acid). Mole weight: 509.17 (free acid). | |
| ATR-101 | ATR-101 is a selective Acetyl CoA C-acetyltransferase inhibitor. ATR-101 is uniquely distributed to adrenal tissues and inhibition of adrenal ACAT1 by ATR-101 disrupts steroidogenesis and leads to selective apoptosis of steroid producing adrenocortical-derived cells. Phase-II clinical trials in Congenital adrenal hyperplasia in USA was on-going. In addiction, Phase I clinical trials in Adrenocortical carcinoma was on-going too. Uses: Congenital adrenal hyperplasia;adrenocortical carcinoma. Synonyms: ATR-101; ATR 101; ATR101; UNII-VK9OS8R205; N-(2,6-Bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea; Damp-cmumep; PD-132301; 133825-81-7 (ATR-101 HCl). Grade: 98%. CAS No. 133825-80-6. Molecular formula: C27H39N3O. Mole weight: 421.63. | |
| ATR-101 HCl | ATR-101 is a selective Acetyl CoA C-acetyltransferase inhibitor. ATR-101 is uniquely distributed to adrenal tissues and inhibition of adrenal ACAT1 by ATR-101 disrupts steroidogenesis and leads to selective apoptosis of steroid producing adrenocortical-derived cells. Phase-II clinical trials in Congenital adrenal hyperplasia in USA was on-going. In addiction, Phase I clinical trials in Adrenocortical carcinoma was on-going too. Uses: Congenital adrenal hyperplasia;adrenocortical carcinoma. Synonyms: ATR-101 HCl; ATR 101 HCl; ATR101 HCl 1-(2,6-diisopropylphenyl)-3-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride; 133825-80-6(free); PD 132301-2; PD132301-2; PD-132301-2. Grade: 98%. CAS No. 133825-81-7. Molecular formula: C27H40ClN3O. Mole weight: 458.09. | |
| Atractyloside sodium salt | Atractyloside sodium salt is a valuable tool in compound used to study mitochondrial dysfunction and its role in diseases such as cancer, liver diseases and cardiovascular disorders. It is a potent inhibitor of mitochondrial adenine nucleotide translocase (ANT). Synonyms: (2β,4α,15α)-15-Hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic Acid Disodium Salt. CAS No. 100938-11-2. Molecular formula: C30H44O16S2Na2. Mole weight: 770.77. | |
| Atracurium | Atracurium is a neuromuscular blocking agent used as a skeletal muscle relaxant. Uses: Nicotinic antagonists. Synonyms: 5-[3-[1-[(3,4-Dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-yl]propanoate. CAS No. 64228-79-1. Molecular formula: C53H72N2O12. Mole weight: 929.14. | |
| Atracurium Besilate EP Impurity A | An impurity of Atracurium besilate. Atracurium besilate is a non-neuromuscular-blocking agent used to relax skeletal muscle. Synonyms: 1-(3,4-dimethoxybenzyl)-2-[13-[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl]-3,11-dioxo-4,10-dioxatridecyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium benzenesulfonate; Atracurium Besylate Impurity A. Molecular formula: C58H74N2O15S. Mole weight: 1071.29. | |
| Atracurium Besilate EP Impurity B | An impurity of Atracurium besilate. Atracurium besilate is a non-neuromuscular-blocking agent used to relax skeletal muscle. Synonyms: pentane-1,5-diyl bis[3-[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl]propanoate]; 1,5-pentanediyl bis[1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-1H-isoquinoline-2-propionate]; Bis[1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinepropanoic acid]1,5-pentanediyl; Atracurium Besylate Impurity B. Grade: 95%. CAS No. 64228-77-9. Molecular formula: C51H66N2O12. Mole weight: 899.08. | |
| Atracurium Besilate EP Impurity C | An impurity of Atracurium besilate. Atracurium besilate is a non-neuromuscular-blocking agent used to relax skeletal muscle. Synonyms: 1-(3,4-dimethoxybenzyl)-2-(3,11-dioxo-4,10-dioxatridec-12-enyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium benzenesulfonate; Atracurium Besylate Impurity C. Molecular formula: C38H49NO11S. Mole weight: 727.87. | |
Our database is helping our users find suppliers everyday.
